Pharmacodynamic analysis from a phase 1 study of rintodestrant (G1T48), an oral selective estrogen receptor degrader, in ER+/HER2-locally advanced or metastatic breast cancer

Philippe Aftimos; Marina Maglakelidze; Andor W. J. M. Glaudemans; Erika Hamilton; Linnea Chap; Elisabeth de Vries; Catharina Willemien Menke-van der Houven van Oordt; Agnes Jager; E. Claire Dees; Massimo Cristofanilli; Mark Pegram; Susanna Ulahannan; Patrick Neven; Iurie Bulat; Ruhi Rai; Wenli Tao; Sarika Jain; Andrew P. Beelen; Jessica A. Sorrentino

Pharmacodynamic analysis from a phase 1 study of rintodestrant (G1T48), an oral selective estrogen receptor degrader, in ER+/HER2-locally advanced or metastatic breast cancer

Philippe Aftimos, Marina Maglakelidze, Andor W. J. M. Glaudemans, Erika Hamilton, Linnea Chap, Elisabeth de Vries, Catharina Willemien Menke-van der Houven van Oordt, Agnes Jager, E. Claire Dees, Massimo Cristofanilli, Mark Pegram, Susanna Ulahannan, Patrick Neven, Iurie Bulat, Ruhi Rai, Wenli Tao, Sarika Jain, Andrew P. Beelen, Jessica A. Sorrentino

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Number of pages	1
Journal	Cancer Research
Volume	81
Issue number	4
Publication status	Published - Feb-2021

Handle.net

Persistent link

Cite this

Aftimos, P., Maglakelidze, M., Glaudemans, A. W. J. M., Hamilton, E., Chap, L., de Vries, E., van Oordt, C. W. M. D. H., Jager, A., Dees, E. C., Cristofanilli, M., Pegram, M., Ulahannan, S., Neven, P., Bulat, I., Rai, R., Tao, W., Jain, S., Beelen, A. P., & Sorrentino, J. A. (2021). Pharmacodynamic analysis from a phase 1 study of rintodestrant (G1T48), an oral selective estrogen receptor degrader, in ER+/HER2-locally advanced or metastatic breast cancer. Cancer Research, 81(4).

@article{6c376e673d33486db50dcfbe5def3a05,

title = "Pharmacodynamic analysis from a phase 1 study of rintodestrant (G1T48), an oral selective estrogen receptor degrader, in ER+/HER2-locally advanced or metastatic breast cancer",

author = "Philippe Aftimos and Marina Maglakelidze and Glaudemans, {Andor W. J. M.} and Erika Hamilton and Linnea Chap and {de Vries}, Elisabeth and {van Oordt}, {Catharina Willemien Menke-van der Houven} and Agnes Jager and Dees, {E. Claire} and Massimo Cristofanilli and Mark Pegram and Susanna Ulahannan and Patrick Neven and Iurie Bulat and Ruhi Rai and Wenli Tao and Sarika Jain and Beelen, {Andrew P.} and Sorrentino, {Jessica A.}",

year = "2021",

month = feb,

language = "English",

volume = "81",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "AMER ASSOC CANCER RESEARCH",

number = "4",

}

Aftimos, P, Maglakelidze, M, Glaudemans, AWJM, Hamilton, E, Chap, L, de Vries, E, van Oordt, CWMDH, Jager, A, Dees, EC, Cristofanilli, M, Pegram, M, Ulahannan, S, Neven, P, Bulat, I, Rai, R, Tao, W, Jain, S, Beelen, AP & Sorrentino, JA 2021, 'Pharmacodynamic analysis from a phase 1 study of rintodestrant (G1T48), an oral selective estrogen receptor degrader, in ER+/HER2-locally advanced or metastatic breast cancer', Cancer Research, vol. 81, no. 4.

Pharmacodynamic analysis from a phase 1 study of rintodestrant (G1T48), an oral selective estrogen receptor degrader, in ER+/HER2-locally advanced or metastatic breast cancer. / Aftimos, Philippe; Maglakelidze, Marina; Glaudemans, Andor W. J. M. et al.
In: Cancer Research, Vol. 81, No. 4, 02.2021.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - Pharmacodynamic analysis from a phase 1 study of rintodestrant (G1T48), an oral selective estrogen receptor degrader, in ER+/HER2-locally advanced or metastatic breast cancer

AU - Aftimos, Philippe

AU - Maglakelidze, Marina

AU - Glaudemans, Andor W. J. M.

AU - Hamilton, Erika

AU - Chap, Linnea

AU - de Vries, Elisabeth

AU - van Oordt, Catharina Willemien Menke-van der Houven

AU - Jager, Agnes

AU - Dees, E. Claire

AU - Cristofanilli, Massimo

AU - Pegram, Mark

AU - Ulahannan, Susanna

AU - Neven, Patrick

AU - Bulat, Iurie

AU - Rai, Ruhi

AU - Tao, Wenli

AU - Jain, Sarika

AU - Beelen, Andrew P.

AU - Sorrentino, Jessica A.

PY - 2021/2

Y1 - 2021/2

M3 - Meeting Abstract

SN - 0008-5472

VL - 81

JO - Cancer Research

JF - Cancer Research

IS - 4

ER -